1018894-97-7

Basic information

• Product Name: tert-butyl 4-(3-(5-chloro-2-methyl-4-nitrophenoxy)propyl)piperazine-1-carboxylate
• Synonyms: tert-butyl 4-(3-(5-chloro-2-methyl-4-nitrophenoxy)propyl)piperazine-1-carboxylate
• CAS NO: 1018894-97-7
• Molecular Weight: 413.901
• Mol File: 1018894-97-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: tert-butyl 4-(3-(5-chloro-2-methyl-4-nitrophenoxy)propyl)piperazine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(3-(5-chloro-2-methyl-4-nitrophenoxy)propyl)piperazine-1-carboxylate(1018894-97-7)
• EPA Substance Registry System: tert-butyl 4-(3-(5-chloro-2-methyl-4-nitrophenoxy)propyl)piperazine-1-carboxylate(1018894-97-7)

Safety Data

• Hazardous Substances Data: 1018894-97-7(Hazardous Substances Data)

Upstream product

• 18349-11-6 1-chloro-5-fluoro-4-methyl-2-nitrobenzene 

Downstream Products

• 1018894-98-8 tert-butyl 4-(3-(4-amino-5-chloro-2-methylphenoxy)propyl)piperazine-1-carboxylate 

Relevant articles and documents

JAK-2 MODULATORS AND METHODS OF USE

This invention relates to the field of protein tyrosine kinases and inhibitors thereof. In particular, the invention relates to inhibitors of JAK-2, pharmaceutical compositions of the compounds for inhibiting JAK-2, methods of inhibiting JAK-2 in a cell, comprising contacting a cell in which inhibition of JAK-2 is desired with a compound or pharmaceutical composition comprising a compound according to the invention. The also comprises methods of treating a disease or condition that involves JAK-2 comprising administering to a patient a pharmaceutical composition comprising a compound according to the invention